Life Sciences
Life Sciences are so much more than a business; they are about changing the world.
While you push the edges of biotech, genetic coding, and pharmaceutical innovation, we can help you reduce exposure and protect your laboratories, equipment, and inventory – as well as your intellectual property.
Life Sciences companies are as varied as the world we live in.
This is one critical reason why Thomas Gregory Associates Insurance Brokers, A OneGroup Company (TGA) does not issue generic, off-the-shelf insurance policies. Life sciences encompass many fields, from biotechnology to epidemiology to medical device production, and as different as each branch may be, there are some commonalities – and many complexities – that must be considered when creating an insurance policy.
TGA works with you and your team to understand the unique requirements of each lab, research center, and manufacturing facility.
We consider ourselves to be part of your advisory team – just as your legal and financial advisors are. We collaborate to ensure that we can effectively customize the policy language to account for any potential exposure, including property loss or damage, loss of intellectual property, potential cyber-breaches, and even product recalls. We are experienced and proven risk managers with the ability to anticipate potential issues. By working together, and combining our experience and knowledge with yours, we can provide customized policies to shield you against today’s risks.
We make it easy for you. Save time. Save money.
2025 Minimum Wage Changes
Whether rising wage requirements are in response to inflation, higher costs of living, constituent demand or a blend of factors, they affect employers.
Snowplow Safety
Operating snowplows is a critical task, especially in regions prone to heavy snowfall. While these machines are essential for maintaining clear and safe roadways, they also pose significant risks if not operated safely.
Legal Alert: Updates to the Consolidated Appropriations Act (CAA) from 2021
When the Consolidated Appropriations Act, 2021 (the “CAA”) was enacted on December 27, 2020, it included a provision that prohibits group health plans and health insurance carriers from entering into certain agreements that, either directly or indirectly, restrict the release of certain information related to provider networks and de-identified encounter data, among other things.